October 3, 2023
Report
Adopting agility in clinical supply labeling
Share
Clinical trial supplies teams are under increasing pressure. Pharmaceutical organizations are asking them to do more trials, with greater complexity, more quickly. The approach is shining a light on operations right across the clinical trials supply chain, including labeling and packaging, as pharma sponsors look to increase R&D efficiencies and shorten the time to study start-up. With labeling frequently a bottleneck, many organizations are recognizing the urgent need to strengthen their labeling capabilities.
This paper explores why an agile clinical supply labeling solution has become business critical for pharmaceutical companies and their clinical services partners. It examines the global trends driving the need to improve labeling operations to shorten development timelines, increase efficiencies, and stimulate growth.
Download this paper to discover:
- Clinical supply labeling systems: Why purpose-built? Why now?
- What must a solution offer to deliver GxP-compliant labeling with consistency, accuracy, and speed?
- How do you implement a purpose-built labeling system to realize value quickly?
- Cloud
- Regulatory
- FDA
- Supply Chain
- Clinical Trials
- Supplier Labeling
- Labeling